[一个不可切除的晚期胃癌病例,对SOX加Nivolumab治疗有完整的病理反应]
Keisuke Yasuda1, Naoki Urakawa, Ryuichiro Sawada
1Division of Gastrointestinal Surgery, Dept. of Surgery, Kobe University Graduate School of Medicine.
Gan to kagaku ryoho. Cancer & chemotherapy
|August 21, 2025
概括
在晚期胃癌中,使用SOX加nivolumab的全身化疗显示出显著的瘤缩小. 将这种治疗与转换手术相结合可能会改善患者的长期结果.
科学领域:
- 癌症学
- 胃肠病学
- 免疫疗法
背景情况:
- 肺转移的晚期胃癌是一个重大的临床挑战.
- 系统化疗是不可切除的晚期胃癌的基石治疗.
- 免疫相关的不良事件可能会使治疗方案复杂化.
研究的目的:
- 评估SOX和nivolumab在患有不可切除的晚期胃癌和肺转移的患者中的疗效.
- 评估新辅助化疗后转换手术的可行性和结果.
- 报告一个成功治疗和长期缓解的病例.
主要方法:
- 一名79岁的男性患有IVB期胃癌和IIa期西格结肠癌,接受了SOX加尼沃卢马布化疗.
- 在6个月内进行了9次化疗,随后对免疫相关的间歇性肺炎进行了类固醇治疗.
- 对胃狭窄进行了 laparoscopic 的远部胃切除术.
- 组织病理学检查评估了对新辅助疗法的反应.
主要成果:
- 观察到主要胃瘤和淋巴结转移的显著缩小.
- 肺转移完全消失.
- 组织病理学分析显示3级组织学反应没有残留的癌细胞.
- 患者在手术后的10个月内没有复发.
结论:
- 在不可切除的晚期胃癌中,SOX加尼沃卢马布具有强烈的瘤缩小作用.
- 在新辅助化疗后的转换手术可能是实现长期缓解的可行策略.
- 这种方法可以改善某些晚期胃癌患者的长期预后.
更多相关视频
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.5K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.3K
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
